查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941457

肿瘤消融市场规模、份额和趋势分析报告：按技术、疗法、应用、地区和细分市场预测，2026-2033年

Tumor Ablation Market Size, Share & Trends Analysis Report By Technology, By Treatment, By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10个工作天内

价格

肿瘤消融市场概述

全球肿瘤消融市场预计到 2025 年将价值 21.4 亿美元，预计到 2033 年将达到 61 亿美元。

预计从 2026 年到 2033 年，其复合年增长率将达到 14.1%。消融术是治疗方法。

这项技术适用于肿瘤数量较少或不适合手术的患者。此外，接受此类治疗的患者无需住院，这促使消融系统在人群中的应用日益普及。包括乳癌、结肠癌、摄护腺癌和肺癌在内的各种癌症发生率不断上升，预计将推动肾臟、软组织、肝臟和骨肿瘤消融技术的需求成长。癌症已被公认为全球性的健康问题，因为它是主要死因之一。例如，根据美国国家卫生统计中心的数据，预计2023年美国将新增约1,958,310例癌症病例，并有609,820例癌症死亡病例。

此外，亚太地区老龄人口的成长，尤其是在日本、印度和中国等拥有巨大未开发市场潜力的国家，预计将在预测期内推动市场扩张。而且，在美国，老年人（65岁及以上）目前是总人口中成长最快的族群。根据美国人口普查局2017年的全国人口估计，到2060年，近四分之一的美国公民将成为老年人。同样的估计也预测，到2030年，整个婴儿潮世代都将年满65岁或以上。

消融设备的科技进步提高了精准度、便携性和成本效益，促使市场相关人员不断研发和改进先进设备。不可逆电穿孔、高强度聚焦超音波，术中成像技术的进步旨在提高治疗品质并最大限度地减少併发症。因此，术中成像技术的进步能够改善治疗准备，并在治疗过程中实现对消融区域的精确评估。

为了维持其强大的市场地位，多家市场参与企业正致力于研发和推出新型消融设备，目前已有数款消融系统正在寻求美国FDA的监管核准。例如，2022年9月，史赛克公司宣布其骨肿瘤消融系统OptaBlate已获得美国FDA的510(k)许可。随着OptaBlate技术的加入，史赛克介入脊椎（IVS）产品线现已为转移性椎体骨折提供全面的治疗方案，进一步拓展了其在椎体增强和射频消融（RFA）方面的核心竞争力。

此外，由于微创手术相比传统手术能减轻病患负担、加速復原速度，其需求日益增长。肿瘤消融术无需切口，因此被认为是非侵入性手术。推动微创手术需求成长的另一个因素是开放性手术相关的感染风险。无创技术能够节省时间和医疗成本，从而缩短住院时间。此外，人口老化和肥胖症的盛行率上升预计也将推动市场成长。世界卫生组织（WHO）预测，到2030年，全球六分之一的人口将达到或超过60岁。这些因素共同促进了肿瘤消融市场的成长。

目录

第一章调查方法和范围

第二章执行摘要

3. 肿瘤消融市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 肿瘤消融市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章 肿瘤消融市场：依技术分類的估计与趋势分析

  • 肿瘤消融市场：技术变革分析
  • 肿瘤消融市场：技术视角
  • 市场规模、预测与趋势分析，2021-2033年
  • 射频消融术
  • 微波消融术
  • 冷冻消融术
  • 不可逆电穿孔消融术
  • HIFU
  • 其他的

第五章 肿瘤消融市场：依疗法分類的估算与趋势

  • 肿瘤消融市场：按疗法分類的差异分析
  • 肿瘤消融市场：按治疗方式分類的视角
  • 市场规模、预测与趋势分析，2021-2033年
  • 外科消融术
  • 腹腔镜消融术
  • 经皮术

第六章：肿瘤消融市场：按应用分類的估算与趋势分析

  • 肿瘤消融市场：按应用分類的差异分析
  • 肿瘤消融市场：按应用领域分類的展望
  • 市场规模、预测与趋势分析，2021-2033年
  • 肾癌
  • 肝癌
  • 乳癌
  • 肺癌
  • 摄护腺癌
  • 其他的

第七章：肿瘤消融市场：区域估算与趋势分析

  • 区域仪錶板
  • 区域肿瘤消融市场波动分析
  • 肿瘤消融市场：区域估计和趋势分析
  • 市场规模、预测与趋势分析，2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 市场参与企业分类
  • 主要企业简介
    • Medtronic plc
    • Boston Scientific Corporation
    • Johnson &Johnson Service Inc.（Ethicon, Inc.）
    • AngioDynamics
    • Bioventus Inc.（Misonix Inc.）
    • EDAP TMS
    • Chongqing Haifu Medical Technology Co., Ltd
    • Mermaid Medical
    • HealthTronics, Inc.
    • HS Hospital Service SpA
Product Code: 978-1-68038-746-9

Tumor Ablation Market Summary

The global tumor ablation market size was estimated at USD 2.14 billion in 2025 and is projected to reach USD 6.10 billion by 2033, growing at a CAGR of 14.1% from 2026 to 2033. Ablation is a treatment that destroys tumors without removing them.

This technique is useful in patients with a few small tumors and, at times, when surgery is not an option. Moreover, patients getting this type of treatment do not need to stay in the hospital, thereby increasing the adoption rate of ablation systems among individuals. Rise in the prevalence of various types of cancers, such as those of breast, colon, prostate, and lung, is anticipated to boost the demand for ablation technologies for the treatment of tumors in the kidney, soft tissue, liver, and bone. Cancer is considered a universal healthcare problem, as it is one of the leading causes of death. For instance, according to the National Center for Health Statistics, in 2023, almost 1,958,310 new cancer cases and 609,820 cancer deaths were estimated in the U.S.

Moreover, the increase in the geriatric population in the Asia Pacific region, especially in countries with large untapped opportunities, such as Japan, India, and China, is expected to drive the market over the forecast period. Furthermore, elderly people (aged >=65) are currently the fastest-growing group among the general population in the U.S. According to the U.S. Census Bureau's 2017 National Population Projections, by 2060, nearly one in four U.S. citizens is likely to be an older adult. According to the same source, by 2030, all baby boomers are expected to be older than 65.

Technological advancements in ablation devices have facilitated accuracy, portability, and cost-effectiveness, encouraging market players to launch and improve advanced devices constantly. Irreversible electroporation, High-intensity focused ultrasound (HIFU), cryoablation, and image-guided equipment are some of the major examples of technological advancements in the market. Alterations in existing technologies and the introduction of novel ablation techniques make it possible to treat larger & more complex tumors in other organs. Furthermore, developments in intraprocedural imaging aim to increase treatment quality and minimize complications. Hence, advancements in intraprocedural imaging have improved treatment preparation and offer accurate assessment of the ablation zone during treatment.

Several market participants aim to develop and launch novel ablation devices to maintain strong positions in the market, and several ablation systems are receiving regulatory approval from the U.S. FDA. For instance, in September 2022, the U.S. FDA granted 510(k) clearance to Stryker's OptaBlate bone tumor ablation system (OptaBlate), according to a statement from Stryker. With the inclusion of OptaBlate technology in its portfolio, company's Interventional Spine (IVS) portfolio now offers a full range of therapeutic options for metastatic vertebral body fractures, expanding on its core capabilities in vertebral augmentation and Radiofrequency Ablation (RFA).

Moreover, demand for minimally invasive procedures is increasing as they result in lower trauma to the patient and facilitate quicker recovery compared to invasive procedures. No incision is required in a tumor ablation procedure, making it noninvasive. Another factor driving the demand for minimally invasive surgeries is the risk of infection during open surgeries. Noninvasive methods decrease hospital stays by saving time and medical costs. Furthermore, a rise in the aging population and the prevalence of obesity is expected to boost market growth. According to the World Health Organization (WHO), 1 in 6 people worldwide will be 60 years or above by 2030. Thes efcators are collectively contributing to the growth of tumor ablation market.

Global Tumor Ablation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global tumor ablation market report based on technology, treatment, application, and region:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation
  • HIFU
  • Other Ablation Technologies
  • Treatment Outlook (Revenue, USD Million, 2021 - 2033)
  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancer
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Treatment
    • 1.2.3. Application
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tumor Ablation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Tumor Ablation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Tumor Ablation Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Tumor Ablation Market: Technology Movement Analysis
  • 4.3. Tumor Ablation Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Radiofrequency Ablation
    • 4.5.1. Radiofrequency Ablation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Microwave Ablation
    • 4.6.1. Microwave Ablation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Cryoablation
    • 4.7.1. Cryoablation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Irreversible Electroporation Ablation
    • 4.8.1. Irreversible Electroporation Ablation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. HIFU
    • 4.9.1. HIFU Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Other Ablation Technologies
    • 4.10.1. Other Ablation Technologies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Tumor Ablation Market: Treatment Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Tumor Ablation Market: Treatment Movement Analysis
  • 5.3. Tumor Ablation Market by Treatment Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Surgical Ablation
    • 5.5.1. Surgical Ablation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Laparoscopic Ablation
    • 5.6.1. Laparoscopic Ablation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Percutaneous Ablation
    • 5.7.1. Percutaneous Ablation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Tumor Ablation Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Tumor Ablation Market: Application Movement Analysis
  • 6.3. Tumor Ablation Market by Application Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Kidney Cancer
    • 6.5.1. Kidney Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Liver Cancer
    • 6.6.1. Liver Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Breast Cancer
    • 6.7.1. Breast Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Lung Cancer
    • 6.8.1. Lung Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.9. Prostate Cancer
    • 6.9.1. Prostate Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.10. Other Cancer
    • 6.10.1. Other Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Tumor Ablation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Tumor Ablation Market Movement Analysis
  • 7.3. Tumor Ablation Market: Regional Estimates & Trend Analysis by Technology & Application
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Europe
    • 7.5.6. Europe Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Tumor Ablation Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Medtronic plc
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Boston Scientific Corporation
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Johnson & Johnson Service Inc. (Ethicon, Inc.)
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. AngioDynamics
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Bioventus Inc. (Misonix Inc.)
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. EDAP TMS
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Chongqing Haifu Medical Technology Co., Ltd
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. Mermaid Medical
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. HealthTronics, Inc.
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. H.S. Hospital Service S.p.A.
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 4 Global Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 5 Global Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 6 North America Tumor Ablation Market, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 8 North America Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 9 North America Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 10 U.S Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 11 U.S Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 12 U.S Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 13 Canada Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 14 Canada Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 15 Canada Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 16 Mexico Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 17 Mexico Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 18 Mexico Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 19 Europe Tumor Ablation Market, by Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 21 Europe Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 22 Europe Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 UK Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 24 UK Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 25 UK Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 26 Germany Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 27 Germany Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 28 Germany Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 29 France Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 30 France Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 31 France Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 32 Italy Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 33 Italy Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 34 Italy Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 35 Spain Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 36 Spain Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 37 Spain Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 38 Denmark Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 39 Denmark Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 40 Denmark Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 41 Sweden Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 42 Sweden Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 43 Sweden Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 44 Norway Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 45 Norway Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 46 Norway Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific Tumor Ablation Market, by Country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 51 Japan Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 52 Japan Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 53 Japan Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 54 China Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 55 China Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 56 China Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 57 India Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 58 India Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 59 India Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 60 Australia Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 61 Australia Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 62 Australia Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 63 South Korea Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 64 South Korea Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 65 South Korea Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 66 Thailand Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 67 Thailand Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 68 Thailand Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 69 Latin America Tumor Ablation Market, by Country, 2021 - 2033 (USD Million)
  • Table 70 Latin America Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 71 Latin America Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 72 Latin America Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 73 Brazil Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 74 Brazil Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 75 Brazil Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 76 Argentina Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 77 Argentina Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 78 Argentina Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa Tumor Ablation Market, by Country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 83 South Africa Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 84 South Africa Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 85 South Africa Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 89 UAE Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 90 UAE Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 91 UAE Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)
  • Table 92 Kuwait Tumor Ablation Market, by Technology, 2021 - 2033 (USD Million)
  • Table 93 Kuwait Tumor Ablation Market, by Treatment, 2021 - 2033 (USD Million)
  • Table 94 Kuwait Tumor Ablation Market, by Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Tumor ablation market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Tumor ablation market, technology outlook key takeaways (USD Million)
  • Fig. 12 Tumor ablation market: technology movement analysis 2025 & 2033 (USD Million)
  • Fig. 13 Radiofrequency ablation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Microwave ablation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Cryoablation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Irreversible electroporation ablation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 HIFU market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Other ablation technologies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Tumor ablation market, treatment outlook key takeaways (USD Million)
  • Fig. 20 Tumor ablation market: treatment movement analysis 2025 & 2033 (USD Million)
  • Fig. 21 Surgical ablation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Laparoscopic ablation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Percutaneous ablation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Tumor ablation market, application outlook key takeaways (USD Million)
  • Fig. 25 Tumor ablation market application movement analysis 2025 & 2033 (USD Million)
  • Fig. 26 Kidney cancer market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Liver cancer market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Breast cancer market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Lung cancer market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Prostate cancer market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Other cancer market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Tumor ablation market, regional key takeaways (USD Million)
  • Fig. 33 Tumor ablation market regional outlook, 2025 & 2033, USD Million
  • Fig. 34 North America tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U.S tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Canada tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Europe tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 UK tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Germany tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 France tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Italy tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Spain tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Denmark tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Sweden tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Norway tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Paciifc tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Japan tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 China tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 India tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Australia tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Argentina tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Middle East & Africa tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 South Africa tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Saudi Arabia tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 UAE tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Kuwait tumor ablation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 List of key emerging company's/indication disruptors/innovators